Compare Cronos Group Inc (CRON) vs Rivian Automotive, Inc. (RIVN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Rivian Automotive, Inc. — how do they compare? Cronos Group Inc trades at $2.74 (market cap $1.02B), while Rivian Automotive, Inc. trades at $17.51 (market cap $25.33B). The key difference: Rivian Automotive, Inc. is far larger — about 24.8× Cronos Group Inc's market cap. Which is the better fit depends on your goals.
| CRON | RIVN | |
|---|---|---|
Market Cap | $1.02B | $25.33B |
Sector | Health | Consumer Cyclical |
52-Week High | $3.27 | $22.45 |
52-Week Low | $1.95 | $11.64 |
Enterprise Value | $203.29M | $27.07B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $2.75, showing no change recently. The stock has a mixed technical outlook with a neutral overall signal but bullish moving averages. Fundamentally, revenue grew to $146.59M in 2025, but net income was negative at -$9.45M. Recent news highlights strong Q1 2026 revenue growth of 40% and expansion of its Spinach brand portfolio, though the company faces intense cannabis sector competition.
Outlook is cautious with growth potential from international expansion and market share gains, but profitability remains a challenge. Risks include regulatory uncertainty and competitive pressures. Analyst sentiment is mixed with 60% hold ratings. The stock presents a speculative opportunity for investors betting on continued top-line growth and eventual margin improvement.
Rivian Automotive (RIVN) trades at $17.31, down 0.97% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $19.22. The company has beaten EPS estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -63.62%. Recent news highlights the potential of the R2 vehicle launch and a $1.74 billion stock offering to fund expansion, creating mixed investor sentiment amid growth prospects and dilution concerns.
The outlook hinges on R2 success and path to profitability, offering upside if execution improves, but high cash burn, competitive pressures, and shareholder dilution present significant risks. Analyst consensus is cautiously optimistic with 44.83% buy ratings, but the stock faces volatility around earnings and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Rivian Automotive, Inc.
Rivian Automotive, Inc. is an automotive technology company. The Company designs and manufactures vans, trucks, and sports utility vehicles, as well as offers repair and maintenance services. Rivian Automotive serves customers in North America and the United Kingdom.
Read more on RIVN →
